NLMK Commence Revamp of Continuous Casting Machine

NLMK has started the installation of main equipment for the revamped Continuous Casting Machine No.3 (CCM) at its main production site in Lipetsk. As a result, CCM production capacity will increase by more than 300 000 tpa, up to 1 mln tpa.

CCM-3 will produce a wide mix of high-quality slabs of various steel grades. State of the art equipment, 20-25% faster casting speeds and longer interrepair periods will boost CCM efficiency. Product mix will expand with an increase in maximum slab thickness from 240 to 315 mm, allowing NLMK to roll wide thick plate at its subsidiaries in Europe (DanSteel, Clabecq).

3 000 tonnes of new equipment manufactured by NKMZ (Ukraine) and NLMK's in-house repair plant will be installed. Launch of the CCM is planned for Q4 2011. Total investments exceed RUR3.7 bln (or about $120 m).

The project is part of the Company's ongoing strategy aimed at the expansion of steelmaking capacity following the start up of the new 3.4 mln tpa Blast Furnace No.7, which's construction is currently in its final stages at the Lipetsk site

For reference:

The main objectives of Stage II of NLMK's Technical Upgrade Program for 2007 - 2012 are:

  • Increase liquid steel capacity by 40% up to 17 mln tpa, including from 9 to 12.4 mln t at the Lipetsk site.
  • Achieve maximum self-sufficiency in key raw materials.
  • Increase finished rolled product output from 8.9 to 10.7 mln tpa due to revamping and construction of new rolling facilities producing finished flats.
  • Increase labour efficiency and reduce environmental impact.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.